News and Trends 26 Sep 2016
UPDATE: AC Immune rakes in €52.5M IPO for assault on Alzheimers
It's not the $700M headlines imply, but AC Immune is winding up to make a splashy IPO of €52.5M to…
Neurological disorders
- Latest Posts
News and Trends 15 Sep 2016
Roche’s New Antibody is besting the best MS Drug
Roche is poised to blow away the competition for the new multiple sclerosis drug with its leading candidate, Ocrevus (ocrelizumab).…
News and Trends 14 Sep 2016
This French Startup brings Gene Therapy to Neurodegenerative Diseases
There were many exciting developments for CNS disease treatments last year, and now a French biotech is winding up to…
News and Trends 9 Sep 2016
Novel biopharma’s therapy for Traumatic Brain Injury heads to Phase III
A German biotech has surfaced with a promising new drug for traumatic brain injury: vasopharm's Nitrous Oxide Synthase inhibitor is starting…
ADVERTISEMENT
News and Trends 30 Aug 2016
New non-amphetaminic ADHD drug ‘speeds’ into Phase II
ADHD is believed to affect up to 7% of people worldwide, but some common therapies bear a shocking resemblance to…
News and Trends 26 Aug 2016
US Money Magnet get hands on UK Bispecific Antibodies for Neurodegenerative Disease
F-star's "plug-and-play" technology can turn any existing antibody into a full-size bispecific antibody. Denali has recognized its potential use for…
News and Trends 8 Aug 2016
The Brain’s Sleep Switch was just discovered, zZz …
Researchers from the University of Oxford have discovered how certain neurons control when we go to sleep. The biology behind…
News and Trends 2 Aug 2016
Google and GSK invest €630M to create a new Bioelectronics Champion
GSK and Verily Life Sciences are creating a new company together, Galvani Bioelectronics. Along with €630M in investment, it'll inherit…
News and Trends 28 Jul 2016
World first Drug to ‘dissolve’ Tau-tangles in Alzheimer’s has Phase III Results
The much-anticipated results of TauRx's Phase III trial for Alzheimer's disease have finally been disclosed. Despite some complicated effects, this could be…
News and Trends 22 Jul 2016
Oryzon develops Epigenetic Therapies against Cancer and Alzheimer’s
This week we're exchanging a very warm and welcoming country for another. We are heading to Barcelona, the wonderful capital of…
ADVERTISEMENT
News and Trends 14 Jul 2016
Sci-fi Spinal Cord Implant could help Paralyzed Patients walk again
Getting up from a wheelchair is a shared dream of paralyzed people all across the world. A dream that might…
News and Trends 14 Jul 2016
French Biotech that makes Drugs faster and cheaper IPO’s for €31M
Pharnext has successfully completed its IPO on the Euronext Paris exchange, allowing it to move forward with Phase II and…
News and Trends 6 Jul 2016
Newly Approved therapy reduces frequency of Multiple Sclerosis relapses by 54%
Biogen and AbbVie have been granted EU marketing authorization for Zinbryta (daclizumab), to treat adult patients with relapsing forms of multiple sclerosis.…
News and Trends 29 Jun 2016
Vienna-based Biotech raises €10M to fight Metabolic diseases and Parkinson’s
AFFiRiS has received €10M from previous investors and one additional backer, adding up to €130M in total funding (half from grants…
News and Trends 23 Jun 2016
Alzheimer’s closer to a Vaccine with new Slovakian Phase II Trial
Axon Neuroscience is starting a Phase II trial with its immunotherapy for Alzheimer's disease, which redirects the immune system against…
News and Trends 14 Jun 2016
New Biomarkers could make Personalized Medicine for Depression
Researchers from King’s College London have succeeded in developing a blood test that can help choose the best treatment for depression…
ADVERTISEMENT
News and Trends 9 Jun 2016
Brain Cell Transplant could help with incurable Neurodegenerative Disease
Researchers from Copenhagen and the US have succeeded in slowing the progression of Huntington's disease in mice with a transplant…
News and Trends 17 May 2016
New Italian Drug is FDA approved for trials in Rare Neurological Disease
Newron sees its Investigational New Drug application approved by the FDA. It can now begin clinical trials for Rett Syndrome patients -…
News and Trends 28 Apr 2016
Interviewing the CSO of the newly €90M fund willing to finally tackle Dementia
I had the chance to talk with Tetsuyuki Maruyama, the CSO of the relatively new Dementia Discovery Fund - our…
News and Trends 27 Apr 2016
French Pleodrug for Rare Neurological Disease opens up phase III trial in US
Pharnext is opening their first US study sites for a phase III trial in a rare neuropathy - a milestone…